CareCloud (CCLD) Aktienübersicht
CareCloud, Inc. ist ein Unternehmen für Informationstechnologie im Gesundheitswesen, das technologiegestützte Geschäftslösungen, Software-as-a-Service-Angebote und damit verbundene Geschäftsdienstleistungen für Gesundheitsdienstleister und Krankenhäuser vor allem in den Vereinigten Staaten anbietet. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 5/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 3/6 |
| Finanzielle Gesundheit | 5/6 |
| Dividenden | 0/6 |
CCLD Community Fair Values
Create NarrativeSee what 36 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CareCloud, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$2.21 |
| 52-Wochen-Hoch | US$4.01 |
| 52-Wochen-Tief | US$2.07 |
| Beta | 1.52 |
| 1 Monat Veränderung | -5.96% |
| 3 Monate Veränderung | -31.58% |
| 1 Jahr Veränderung | -6.36% |
| 3 Jahre Veränderung | -22.46% |
| 5 Jahre Veränderung | -73.75% |
| Veränderung seit IPO | -48.36% |
Aktuelle Nachrichten und Updates
Narrativ-Update • Jul 01
CCLD: AI Solutions And Margin Gains Will Support Credit-Funded Expansion
Analysts have trimmed their CareCloud price target from $3.25 to $2.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together point to a more conservative outlook for the stock. What's in the News for CareCloud CareCloud redeemed 100% of its 8.75% Series B Preferred Stock.
Narrativ-Update • Jun 16
CCLD: Balance Sheet Reshaping And 2026 Guidance Will Support Bullish Repricing
Analysts have adjusted their price target on CareCloud to $8.00, reflecting updated assumptions around revenue growth, profit margins, discount rate and future P/E that they consider better aligned with the company’s current outlook. What’s in the News for CareCloud CareCloud fully redeemed all outstanding 8.75% Series B Preferred Stock, funded with a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank.Narrativ-Update • Jun 02
CCLD: Capital Reshaping And 2026 Outlook Will Clarify Underlying Revenue Trends
Analysts have reduced their price target on CareCloud to $3.25, citing concern that recent acquisitions, including plans to acquire an aircraft for client visits, may be obscuring underlying revenue declines. What's in the News CareCloud redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank, as part of a multi year capital structure shift.Narrativ-Update • May 13
CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential
Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.Analyseartikel • May 11
The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...Recent updates
Narrativ-Update • Jul 01
CCLD: AI Solutions And Margin Gains Will Support Credit-Funded Expansion
Analysts have trimmed their CareCloud price target from $3.25 to $2.50, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E, which together point to a more conservative outlook for the stock. What's in the News for CareCloud CareCloud redeemed 100% of its 8.75% Series B Preferred Stock.Narrativ-Update • Jun 16
CCLD: Balance Sheet Reshaping And 2026 Guidance Will Support Bullish Repricing
Analysts have adjusted their price target on CareCloud to $8.00, reflecting updated assumptions around revenue growth, profit margins, discount rate and future P/E that they consider better aligned with the company’s current outlook. What’s in the News for CareCloud CareCloud fully redeemed all outstanding 8.75% Series B Preferred Stock, funded with a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank.Narrativ-Update • Jun 02
CCLD: Capital Reshaping And 2026 Outlook Will Clarify Underlying Revenue Trends
Analysts have reduced their price target on CareCloud to $3.25, citing concern that recent acquisitions, including plans to acquire an aircraft for client visits, may be obscuring underlying revenue declines. What's in the News CareCloud redeemed 100% of its 8.75% Series B Preferred Stock, funded by a new US$50 million credit facility led by Citizens Bank with participation from Provident Bank, as part of a multi year capital structure shift.Narrativ-Update • May 13
CCLD: Clearer Organic Revenue Trends Will Support Future Upside Potential
Analysts have trimmed their average price target on CareCloud to $3.25, citing concerns that recent acquisitions, including a planned aircraft purchase, are masking underlying revenue declines and adding nonessential spending to the story. Analyst Commentary Bullish analysts are weighing CareCloud's recent moves against concerns around revenue trends and spending, and are looking closely at how management deploys capital from acquisitions and new initiatives.Analyseartikel • May 11
The CareCloud, Inc. (NASDAQ:CCLD) First-Quarter Results Are Out And Analysts Have Published New Forecasts
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its quarterly...
Narrativ-Update • Apr 29
CCLD: Capital Discipline And AI Adoption Will Drive Future Repricing Confidence
Analysts have adjusted their price target on CareCloud to $6.31, citing concerns that acquisitive activity and plans for an aircraft purchase may be obscuring underlying revenue softness and creating questions around capital allocation discipline. Analyst Commentary Analyst commentary around CareCloud centers on how acquisitions and capital allocation choices, including the planned aircraft purchase, may influence the company’s ability to deliver consistent execution and support the current valuation.Narrativ-Update • Apr 14
CCLD: Cost Controls And AI Automation Will Offset Acquisition And Aircraft Spending
Analysts have reaffirmed their $3.25 price target on CareCloud, citing recent results as reasonable. However, they expressed concern that acquisitions, including a planned aircraft purchase for client visits, may be obscuring the company’s underlying revenue trends.Narrativ-Update • Mar 31
CCLD: Clearer Organic Revenue Disclosure Will Support Future Upside Potential
Narrative Update on CareCloud Analysts have reduced their CareCloud price target to $3.25, reflecting concerns that recent acquisitions and the planned aircraft purchase may be masking underlying revenue declines rather than supporting a stronger long term outlook. Analyst Commentary Recent commentary points to a cautious stance on CareCloud, with the current US$3.25 price target described as reflecting concern that acquisitions and the planned aircraft purchase may be masking underlying revenue pressure rather than supporting a clearer long term growth story.Narrativ-Update • Mar 17
CCLD: Higher Margins And New Contracts Will Support Future Upside
Analysts have trimmed CareCloud's price target to $3.25. This reflects concerns that acquisitive activity, including the planned aircraft purchase, is obscuring underlying revenue softness, even as profit margin assumptions improve and future P/E expectations reset lower.Narrativ-Update • Mar 02
CCLD: Supply Chain And Urgent Care Expansion Will Support Future Upside
Analysts have adjusted their CareCloud price target to reflect updated assumptions on discount rate, revenue growth, profit margin, and future P/E. This has led to a revised view of the potential upside for the shares.Narrativ-Update • Feb 16
CCLD: Cost Controls And AI Automation Will Drive Future Repricing Potential
Analysts have updated their view on CareCloud with a revised $3.25 price target, citing refreshed assumptions for revenue growth, profit margins, discount rate and future P/E, while also pointing to recent Street research, including new coverage with an $8 target, as context for the valuation range. Analyst Commentary The refreshed $3.25 target sits well below the new $8 initiation level referenced in Street research, which highlights how split opinions are around CareCloud’s execution and valuation.Analyseartikel • Feb 04
Take Care Before Diving Into The Deep End On CareCloud, Inc. (NASDAQ:CCLD)
You may think that with a price-to-sales (or "P/S") ratio of 0.9x CareCloud, Inc. ( NASDAQ:CCLD ) is a stock worth...Narrativ-Update • Feb 02
CCLD: Cost Discipline And AI Rollout Will Support Future Rerating Potential
Analysts have nudged their price target for CareCloud higher, with some recent research pointing to a range up to US$8. This reflects revised assumptions for cost controls, a flatter near term revenue and EBITDA outlook, and a higher future P/E multiple in their models.Seeking Alpha • Jan 29
CareCloud: Undervalued AI Play In Healthcare IT
Summary CareCloud is transitioning from an RCM provider to AI-driven healthcare IT, targeting higher-margin recurring revenues. I assign CCLD a buy rating with a 1-year price target of $4.3, implying 48% upside from $2.9. Recent performance shows six consecutive quarters of GAAP profitability, strong cost control, and solid operating cash flow. Key risks include 2026 state AI regulations, which may limit adoption of CCLD’s new AI voice solutions. Read the full article on Seeking AlphaNarrativ-Update • Jan 19
CCLD: Cost Controls And AI Automation Will Support Future Repricing
Analysts have adjusted their price target on CareCloud to $3.25 based on updated views of revenue growth, profit margins, cost controls, and long-term P/E assumptions following recent research, including new coverage with an $8 target and revised estimates after the latest Q3 report. Analyst Commentary Recent research on CareCloud reflects a mix of optimism and restraint, with one firm starting coverage at a higher price target and others resetting expectations closer to current fundamentals.Narrativ-Update • Jan 05
CCLD: Cost Controls And New AI Offering Will Support Future Upside
Narrative Update on CareCloud Analysts have lifted their price target on CareCloud to $3.25 from $2.25, citing updated forecasts for revenue growth, a different margin profile, a higher assumed future P/E multiple, and recent Street research that includes new coverage and refreshed estimates following the Q3 report. Analyst Commentary Recent Street research on CareCloud offers a mixed picture, with some upbeat coverage alongside more cautious views.Narrativ-Update • Dec 15
CCLD: Cost Controls And EBITDA Durability Will Drive Shares Higher
Analysts have raised their price target on CareCloud to $8.00 from prior levels near $3.25, citing new Buy-rated coverage and expectations that tighter cost controls will support near term EBITDA even as revenue growth moderates. Analyst Commentary Bullish analysts point to recent price target increases as evidence that the market may be underestimating CareCloud's ability to sustain profitability while navigating slower top line growth.Narrativ-Update • Dec 01
CCLD: Improved Cost Controls Will Sustain Near-Term Profitability Momentum
CareCloud's analyst price target has increased from $5.75 to $6.31, reflecting a slightly improved near-term outlook as analysts cite cost controls and recent Buy ratings, even as revenue and margin expectations moderate. Analyst Commentary Recent analyst notes on CareCloud highlight both positive and cautious perspectives regarding the company’s outlook and valuation.Narrativ-Update • Nov 17
CCLD: Improved Cost Controls Will Drive Higher Near-Term Profitability
CareCloud's analyst price target has been raised by $1.00 to $3.25, as analysts point to improved cost controls and a stable near-term earnings outlook following recent updates to estimates. Analyst Commentary Following recent updates, analysts have offered perspectives highlighting both the positive developments and ongoing concerns for CareCloud.Analyseartikel • Aug 26
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 30% Share Price Rise
Despite an already strong run, CareCloud, Inc. ( NASDAQ:CCLD ) shares have been powering on, with a gain of 30% in the...Analyseartikel • May 01
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues Despite A 33% Share Price Rise
Those holding CareCloud, Inc. ( NASDAQ:CCLD ) shares would be relieved that the share price has rebounded 33% in the...
Neues Narrativ • Apr 12
CirrusAI, Series Conversion And Acquisition Reentry Will Unlock New Opportunities
AI-driven solutions and innovations, including CirrusAI, position CareCloud for enhanced revenue growth and new market opportunities.Analyseartikel • Mar 16
Analysts Have Been Trimming Their CareCloud, Inc. (NASDAQ:CCLD) Price Target After Its Latest Report
There's been a notable change in appetite for CareCloud, Inc. ( NASDAQ:CCLD ) shares in the week since its annual...Analyseartikel • Mar 13
Not Many Are Piling Into CareCloud, Inc. (NASDAQ:CCLD) Stock Yet As It Plummets 65%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders won't be pleased to see that the share price has had a very rough month...Analyseartikel • Feb 19
CareCloud (NASDAQ:CCLD) Is Looking To Continue Growing Its Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analyseartikel • Jan 18
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 25%
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 25% in the last month, reversing a fair amount of...Analyseartikel • Nov 13
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 34% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders have had their patience rewarded with a 34% share price jump in the last...Analyseartikel • Oct 07
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Aug 31
CareCloud, Inc. (NASDAQ:CCLD) Shares Fly 25% But Investors Aren't Buying For Growth
CareCloud, Inc. ( NASDAQ:CCLD ) shares have had a really impressive month, gaining 25% after a shaky period beforehand...Analyseartikel • Jul 13
CareCloud, Inc. (NASDAQ:CCLD) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
CareCloud, Inc. ( NASDAQ:CCLD ) shares have retraced a considerable 26% in the last month, reversing a fair amount of...Analyseartikel • Jun 27
We Think CareCloud (NASDAQ:CCLD) Has A Fair Chunk Of Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • May 22
CareCloud, Inc. (NASDAQ:CCLD) Held Back By Insufficient Growth Even After Shares Climb 158%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders would be excited to see that the share price has had a great month...Analyseartikel • Mar 22
CareCloud, Inc. (NASDAQ:CCLD) Shares Could Be 42% Below Their Intrinsic Value Estimate
Key Insights CareCloud's estimated fair value is US$1.92 based on 2 Stage Free Cash Flow to Equity CareCloud is...Analyseartikel • Mar 22
The Market Doesn't Like What It Sees From CareCloud, Inc.'s (NASDAQ:CCLD) Revenues Yet As Shares Tumble 27%
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Analyseartikel • Feb 02
Little Excitement Around CareCloud, Inc.'s (NASDAQ:CCLD) Revenues As Shares Take 25% Pounding
The CareCloud, Inc. ( NASDAQ:CCLD ) share price has softened a substantial 25% over the previous 30 days, handing back...Analyseartikel • Jan 30
Is CareCloud (NASDAQ:CCLD) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analyseartikel • Dec 19
CareCloud, Inc.'s (NASDAQ:CCLD) 31% Dip In Price Shows Sentiment Is Matching Revenues
CareCloud, Inc. ( NASDAQ:CCLD ) shareholders that were waiting for something to happen have been dealt a blow with a...Analyseartikel • Sep 28
Is CareCloud (NASDAQ:CCLD) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Aug 05
Things Look Grim For CareCloud, Inc. (NASDAQ:CCLD) After Today's Downgrade
Today is shaping up negative for CareCloud, Inc. ( NASDAQ:CCLD ) shareholders, with the analysts delivering a...Analyseartikel • Aug 01
There's No Escaping CareCloud, Inc.'s (NASDAQ:CCLD) Muted Revenues
With a price-to-sales (or "P/S") ratio of 0.4x CareCloud, Inc. ( NASDAQ:CCLD ) may be sending very bullish signals at...Aktionärsrenditen
| CCLD | US Healthcare Services | US Markt | |
|---|---|---|---|
| 7D | 2.3% | 6.9% | 0.8% |
| 1Y | -6.4% | -35.6% | 20.2% |
Rendite im Vergleich zur Industrie: CCLD übertraf die Branche US Healthcare Services , die im vergangenen Jahr eine Rendite von -37 erzielte.
Rendite vs. Markt: CCLD hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 18.6 erzielte.
Preisvolatilität
| CCLD volatility | |
|---|---|
| CCLD Average Weekly Movement | 9.2% |
| Healthcare Services Industry Average Movement | 9.9% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: CCLD hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: CCLDDie wöchentliche Volatilität (9%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1999 | 3,650 | Stephen Snyder | www.carecloud.com |
CareCloud, Inc. ist ein Unternehmen für Informationstechnologie im Gesundheitswesen, das technologiegestützte Geschäftslösungen, Software-as-a-Service-Angebote und damit verbundene Geschäftsdienstleistungen für Gesundheitsdienstleister und Krankenhäuser vor allem in den Vereinigten Staaten anbietet. Das Unternehmen ist in den Segmenten Healthcare IT und Medical Practice Management tätig. Die firmeneigene Software und Business Services umfasst Technologie-fähige Business-Lösungen, Cloud-basierte Software, Digital Health Services, Healthcare IT professionelle Dienstleistungen und Personal, MAP App, und medizinische Praxis-Management-Dienstleistungen.
CareCloud, Inc.'s Grundlagenzusammenfassung
| CCLD grundlegende Statistiken | |
|---|---|
| Marktanteil | US$94.33m |
| Gewinn(TTM) | US$4.31m |
| Umsatz(TTM) | US$124.14m |
21.8x
Kurs-Gewinn-Verhältnis 0.8x
Kurs-Umsatz-VerhältnisIst CCLD zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| CCLD Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$124.14m |
| Kosten der Einnahmen | US$65.84m |
| Bruttogewinn | US$58.30m |
| Sonstige Ausgaben | US$53.98m |
| Gewinn | US$4.31m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 0.10 |
| Bruttomarge | 46.96% |
| Nettogewinnspanne | 3.47% |
| Schulden/Eigenkapital-Verhältnis | 1.7% |
Wie hat sich CCLD auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/06 02:41 |
| Aktienkurs zum Tagesende | 2026/07/06 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
CareCloud, Inc. wird von 8 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Keay Nakae | Chardan Capital Markets, LLC |
| Eugene Mannheimer | Colliers Securities |